Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Researchers improve cisplatin-induced ototoxicity model

Feb. 10, 2022

SENS-401 shows good local bioavailability in sensorineural hearing loss model

Feb. 9, 2022

Rockefeller University presents new LATS1 inhibitors

Sep. 1, 2021

Otonomy announces phase I/II study expansion for OTO-413 in speech-in-noise hearing difficulty

June 16, 2021

Frequency Therapeutics reports phase IIa data on FX-322 in sensorineural hearing loss

March 23, 2021

Gene therapy for TMPRSS3 hearing loss shows promise with late intervention in mouse model

March 8, 2021

Decibel Therapeutics presents DB-OTO for genetic hearing loss

Feb. 25, 2021

Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype

Feb. 25, 2021

Phase III trial of Otividex for Meniere's disease does not meet primary endpoint

Feb. 25, 2021

Targeting AMPK-alpha prevents drug-induced hair cell loss and hearing loss

Feb. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...